<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Physiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id><journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id><journal-title-group><journal-title>Frontiers in Physiology</journal-title></journal-title-group><issn pub-type="epub">1664-042X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24624090</article-id><article-id pub-id-type="pmc">3940064</article-id><article-id pub-id-type="doi">10.3389/fphys.2014.00081</article-id><article-categories><subj-group subj-group-type="heading"><subject>Physiology</subject><subj-group><subject>Original Research Article</subject></subj-group></subj-group></article-categories><title-group><article-title>Effect of phenylephrine vs. ephedrine on frontal lobe oxygenation during caesarean section with spinal anesthesia: an open label randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Foss</surname><given-names>Visti T.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Christensen</surname><given-names>Robin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rokamp</surname><given-names>Kim Z.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nissen</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Secher</surname><given-names>Niels H.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nielsen</surname><given-names>Henning B.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Anaesthesia, N&#x000e6;stved Hospital</institution><country>N&#x000e6;stved, Denmark</country></aff><aff id="aff2"><sup>2</sup><institution>Musculoskeletal Statistics Unit, Department of Rheumatology, The Parker Institute, Frederiksberg Hospital, University of Copenhagen</institution><country>Copenhagen, Denmark</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Anaesthesia, Rigshospitalet, University of Copenhagen</institution><country>Copenhagen, Denmark</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Patrice Brassard, Laval University, Canada</p></fn><fn fn-type="edited-by"><p>Reviewed by: Ashraf Habib, Duke University, USA; Samuel J. E. Lucas, University of Birmingham, UK</p></fn><corresp id="fn001">*Correspondence: Visti T. Foss, Department of Anaesthesia, N&#x000e6;stved Hospital, Ringstedgade 61, 4700 N&#x000e6;stved, Denmark e-mail: <email xlink:type="simple">vistifoss@gmail.com</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Integrative Physiology, a section of the journal Frontiers in Physiology.</p></fn></author-notes><pub-date pub-type="epub"><day>03</day><month>3</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>5</volume><elocation-id>81</elocation-id><history><date date-type="received"><day>22</day><month>11</month><year>2013</year></date><date date-type="accepted"><day>08</day><month>2</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Foss, Christensen, Rokamp, Nissen, Secher and Nielsen.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><bold>Background:</bold> During caesarean section spinal anesthesia may provoke maternal hypotension that we prevent by administration of phenylephrine and/or ephedrine. Phenylephrine is however reported to reduce the near infrared spectroscopy-determined frontal lobe oxygenation (ScO<sub>2</sub>) but whether that is the case for patients exposed to spinal anesthesia is not known.</p><p><bold>Objectives:</bold> To evaluate the impact of phenylephrine vs. ephedrine on ScO<sub>2</sub>during caesarean section with spinal anesthesia in a single center, open-label parallel-group study with balanced randomization of 24 women (1:1). Secondary aims were to compare the effect of the two drugs on maternal hemodynamics and fetal heart rate.</p><p><bold>Intervention:</bold> Ephedrine (0.8&#x02013;3.3 mg/min) <italic>vs.</italic> phenylephrine infusion (0.02&#x02013;0.07 mg/min).</p><p><bold>Results:</bold> For the duration of surgery, administration of ephedrine maintained ScO<sub>2</sub> (compared to baseline +2.1 &#x000b1; 2.8%; mean &#x000b1; SE, while phenylephrine reduced ScO<sub>2</sub> (&#x02212;8.6 &#x000b1; 2.8%; <italic>p</italic> = 0.005) with a 10.7% difference in ScO<sub>2</sub>between groups (<italic>p</italic> = 0.0106). Also maternal heart rate was maintained with ephedrine (+3 &#x000b1; 3 bpm) but decreased with phenylephrine (&#x02212;11 &#x000b1; 3 bpm); difference 14 bpm (<italic>p</italic> = 0.0053), but no significant difference in mean arterial pressure (<italic>p</italic> = 0.1904) or CO (<italic>p</italic> = 0.0683) was observed between groups. The two drugs also elicited an equal increase in fetal heart rate (by 19 &#x000b1; 3 vs. 18 &#x000b1; 3 bpm; <italic>p</italic> = 0.744).</p><p><bold>Conclusion:</bold> In the choice between phenylephrine and ephedrine for maintenance of blood pressure during caesarean section with spinal anesthesia, ephedrine maintains frontal lobe oxygenation and maternal heart rate with a similar increase in fetal heart rate as elicited by phenylephrine.</p><p><bold>Trial registration:</bold> Clinical trials NCT 01509521 and EudraCT 2001 006103 35.</p></abstract><kwd-group><kwd>cerebral autoregulation</kwd><kwd>drug effect</kwd><kwd>heart rate</kwd><kwd>fetal</kwd><kwd>near infrared spectroscopy</kwd><kwd>vasoconstrictor agents</kwd></kwd-group><counts><fig-count count="4"/><table-count count="4"/><equation-count count="0"/><ref-count count="44"/><page-count count="9"/><word-count count="6260"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Spinal anesthesia is used for caesarean section although it is commonly associated with hypotension. In addition to tilting patient to the left and providing i.v. fluids, we use ephedrine and/or phenylephrine to prevent or correct hypotension that could result in, e.g., dizziness, nausea, and vomiting and also hinder adequate perfusion of the child (Berlac and Rasmussen, <xref rid="B1" ref-type="bibr">2005</xref>; Cyna et al., <xref rid="B5" ref-type="bibr">2006</xref>; Saravanan et al., <xref rid="B36" ref-type="bibr">2006</xref>; Ngan Kee et al., <xref rid="B27" ref-type="bibr">2008a</xref>).</p><p>The effect of ephedrine and phenylephrine on maternal and fetal hemodynamics has been investigated extensively (Mercier et al., <xref rid="B26" ref-type="bibr">2001</xref>; Saravanan et al., <xref rid="B36" ref-type="bibr">2006</xref>; Langesaeter et al., <xref rid="B17" ref-type="bibr">2008</xref>; Ngan Kee et al., <xref rid="B27" ref-type="bibr">2008a</xref>) There seems to be no difference between the two drugs in regards to preventing hypotension following spinal anesthesia for caesarean section (Cyna et al., <xref rid="B5" ref-type="bibr">2006</xref>) However, fetal tachycardia appears to be more frequent with the use of ephedrine, or combined ephedrine and phenylephrine than with the use of phenylephrine (Wang et al., <xref rid="B43" ref-type="bibr">2011</xref>) Furthermore, the effect of phenylephrine on fetal acid base status seems to be more favorable than manifested with the use of ephedrine (Vesser et al., <xref rid="B42" ref-type="bibr">2012</xref>).</p><p>On the other hand, near infrared spectroscopy (NIRS) determined cerebral (frontal lobe) oxygenation (ScO<sub>2</sub>) decreases when hypotension is supported by phenylephrine (Nissen et al., <xref rid="B30" ref-type="bibr">2009a</xref>, <xref rid="B29" ref-type="bibr">2010</xref>; Ogoh et al., <xref rid="B33" ref-type="bibr">2011</xref>; Meng et al., <xref rid="B23" ref-type="bibr">2011a</xref>) while it is maintained with the use of ephedrine (Nissen et al., <xref rid="B29" ref-type="bibr">2010</xref>; Meng et al., <xref rid="B23" ref-type="bibr">2011a</xref>; Ogoh et al., <xref rid="B33" ref-type="bibr">2011</xref>) We investigated how phenylephrine and ephedrine influence ScO<sub>2</sub> when used to prevent maternal hypotension during caesarean section performed under spinal anesthesia where phenylephrine may hinder accumulation of blood in the blocked area of the body and thereby support cardiac output (CO)(Cannesson et al., <xref rid="B3" ref-type="bibr">2012</xref>) and in turn ScO<sub>2</sub>. Thus, we hypothesized that administration of both ephedrine and phenylephrine would maintain ScO<sub>2</sub> in patients undergoing caesarean section with spinal anesthesia since an increase in vascular tone can enhance venous return and thereby support cardiac preload and CO during hypovolemia as demonstrated in anesthetized pigs (Cannesson et al., <xref rid="B3" ref-type="bibr">2012</xref>) In this randomized clinical trial the primary outcome was to evaluate the ScO<sub>2</sub> response to administration of ephedrine vs. phenylephrine. Secondary aims were to evaluate changes in maternal hemodynamics and in fetal heart rate. Umbilical cord blood gas variables were also determined.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><p>For this single center, open label, parallel-group study with balanced randomization (1:1), written informed consent was obtained from healthy women undergoing elective caesarean section during spinal anesthesia after approval by the local ethics committee (SJ&#x02014;271) and the Danish medicine agency (NCT 01509521; EudraCT 2001 006103 35). The Good Clinical Practice (GCP) unit at the University of Copenhagen monitored the trial conducted from April 2012 to July 2012 at N&#x000e6;stved Hospital. Eligible participants were older than 18 years in ASA group I or II, 160&#x02013;180 cm and with a single pregnancy. Patients with either preeclampsia, non-singleton pregnancy, HELLP-syndrome (hemolysis, elevated liver enzyme, low platelet count), elevated serum bilirubin, or reported allergy to ephedrine or phenylephrine were excluded from the study.</p></sec><sec><title>Preparation</title><p>Upon arrival to the operating theater, the patient was provided with 500 mL isotonic saline, tilted 15&#x000b0; to the left and nasal supplementation of oxygen (2 L/min) was established. A cuff was applied to the third finger of the left hand and heart rate (HR), systolic (SBP), diastolic (DBP) and mean arterial (MAP) blood pressures were determined by Nexfin (BMEYE, The Netherlands, Amsterdam). Thus stroke volume (SV) was determined from the pressure curve using Modelflow (Bogert and van Lieshout, <xref rid="B2" ref-type="bibr">2005</xref>) that takes sex, age, and weight into account. CO (SV times HR) and total peripheral resistance (TPR; MAP divided by CO) were calculated. Nexfin data were obtained on a beat to beat basis and averaged over 15 s every 2.5 min. Fetal HR was obtained by Doppler (Sonicaid Dopplers, Luton, Huntleigh, UK) and averaged over 15 s from before spinal anesthesia (baseline) and after spinal anesthesia (2.5&#x02013;5 min), during surgery (7.5&#x02013;17.5 min), and after delivery (13&#x02013;28 min).</p></sec><sec><title>Spinal anesthesia</title><p>With 2.4 mL bupivacaine 0.5% (12 mg) and 10 &#x003bc;g fentanyl spinal anesthesia was established using a 27 or 25 G pencil point needle at the L2&#x02013;L3 or L3&#x02013;L4 intervertebral space. Spinal anesthesia was administered in the right lateral position in 21 patients and in three patients spinal anesthesia was provided in a seated position. Surgery started when the sensory block included the T5 dermatome as indicated by the loss of sensation to application of cold to the skin.</p></sec><sec><title>Frontal lobe oxygenation</title><p>ScO<sub>2</sub> was monitored by NIRS (INVOS 3100 Cerebral Oxymeter, Somanetics, Troy, USA). Optodes were placed on both sides of the forehead immediately below the hairline and secured with a headband that also served to seal ambient light. The NIRS-determined mean ScO<sub>2</sub> is based on optodes that emit and detect near-infrared light at two wavelengths (730 and 810 nm) and ScO<sub>2</sub> is calculated as the ratio between oxyhemoglobin and total hemoglobin. The signal detector closest to the light source (3 cm) is considered the &#x0201c;shallow detector&#x0201d; and used to attenuate influence from superficial tissue, while the detector 4 cm from the light source is considered to detect light from &#x0201c;deep tissue.&#x0201d; The distance between the source and detectors is considered sufficient for light to reach the brain (Choi et al., <xref rid="B4" ref-type="bibr">2004</xref>) Thus it was assumed that values are accounted for predominantly by hemoglobin in the frontal lobe cortex, although a contribution from the skin is acknowledged (Davie and Grocott, <xref rid="B7" ref-type="bibr">2012</xref>).</p></sec><sec><title>Interventions and randomization</title><p>The patients were allocated randomly into two groups (ephedrine or phenylephrine) of 12 using sequentially numbered, opaque, sealed envelopes prepared by an individual not involved in the study. Dose equivalence between phenylephrine (0.1 mg/mL) and ephedrine (5 mg/mL) was chosen in according to previous trials and recommendations (Saravanan et al., <xref rid="B36" ref-type="bibr">2006</xref>; Ngan Kee et al., <xref rid="B28" ref-type="bibr">2008b</xref>; Das et al., <xref rid="B6" ref-type="bibr">2011</xref>).</p><p>After spinal anesthesia, the infusion was started (20 ml/h; 1.6 mg/min for ephedrine and 0.03 mg/min for phenylephrine) and adjusted to maintain SBP. If SBP increased from baseline by 10&#x02013;20%, the infusion was reduced to 10 mL/h and paused if SBP increased more than 20%. Conversely, if SBP decreased by 10&#x02013;20%, the infusion was increased to 40 mL/h. A bolus of either 10 mg ephedrine or 0.2 mg phenylephrine was to be administered if SBP decreased by more than 20%, or if the patient complained of symptoms of hypotension (dizziness, vomiting, faintness, nausea). At delivery the infusion was reduced to 10 mL/h and terminated 5&#x02013;15 min thereafter. Data collected included Apgar score, and umbilical arterial and venous blood gas variables from a double-clamped cord segment. Further, data pertaining to the duration of surgery, volume of saline administered and the vasopressor dosages used are mentioned.</p></sec><sec><title>Outcome measures</title><p>The primary outcome is expressed as the percentage ScO<sub>2</sub> change from baseline, with baseline defined as rest prior to spinal anesthesia (time 0 min). The secondary outcomes variables (maternal hemodynamics and fetal heart rate) were also expressed as the change from baseline and all observations were continued until the end of surgery.</p></sec><sec><title>Statistical analysis</title><p>Power calculations based on former studies (Nissen et al., <xref rid="B29" ref-type="bibr">2010</xref>; Kim et al., <xref rid="B15" ref-type="bibr">2000</xref>) revealed that in order to detect a statistically significant difference between means of 57 and 67% in ScO<sub>2</sub>, assuming a common standard deviation of 7%, a sample size of <italic>n</italic> = 9 per group was required to obtain a power of a least 0.8 (&#x003b2; = 20%; two-tailed &#x003b1; = 5%). To compensate for potential dropouts and missing data (25%) the sample size was increased to 12 participants per group. Data analyses were according to a pre-established plan using SAS software (v. 9.2; SAS Institute Inc., Cary, NC, USA). Descriptive statistics and tests are reported in accordance with the &#x0201c;Enhancing the QUAlity and Transparency Of health Research&#x0201d; (EQUATOR) network: the CONSORT Statement (Schulz et al., <xref rid="B37" ref-type="bibr">2010</xref>). In order to evaluate data distribution of the outcome and statistical models, inspection was used to suggest whether the assumption of normality was reasonable. The PROC UNIVARIATE statement was used to summarize descriptive data. If the assumption of normality was not reasonable, we analyzed the data with the nonparametric Wilcoxon Rank Sum test using PROC NPAR1WAY; and the median difference was reported. The 95% confidence limit was estimated from an approximated standard error, based on the Wilcoxon <italic>p</italic>-value from a Wald-<italic>Z</italic>-test.</p><p>To analyse the longitudinal element of the study objectives, a linear approach was used for repeated measurements, using the procedure PROC MIXED based on restricted maximum likelihood (REML) estimates of the variables (Littell et al., <xref rid="B19" ref-type="bibr">2000</xref>). The factor <italic>Subject</italic> was applied as a random effect factor. Assessment of the treatment and time effects tested possible interaction and both treatment and time were included as systematic factors using the baseline value as co-variate to reduce random variation and increase power. Unless stated otherwise, results are expressed as the difference between the group means and 95% CI with the associated <italic>p</italic>-values, based on the mixed linear model. The average change from the baseline during the study in each group was analyzed based on the mixed model with only the main effects of group and time without taking interaction into account. All comparisons were two tailed and <italic>p</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec><sec sec-type="results" id="s3"><title>Results</title><sec><title>Patients</title><p>Written informed consent to participate in the study was obtained from 33 patients; 24 of whom were subsequently randomized (Figure <xref ref-type="fig" rid="F1">1</xref>) and the randomized patients had a body mass index of 30.1 (5.4) mean (SD), range 21.6&#x02013;41.6 kg/m<sup>2</sup> (Table <xref ref-type="table" rid="T1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Trial profile</bold>.</p></caption><graphic xlink:href="fphys-05-00081-g0001"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Patient characteristics, cardiovascular values, fetal heart rate, and frontal lobe oxygenation at baseline</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"><bold>Ephedrine <bold><italic>N</italic></bold> = <bold>12</bold></bold></th><th align="center" rowspan="1" colspan="1"><bold>Phenylephrine <bold><italic>N</italic></bold> = <bold>12</bold></bold></th><th align="center" rowspan="1" colspan="1"><bold>Total <bold><italic>N</italic></bold> = <bold>24</bold></bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">30.8 &#x000b1; 5.5</td><td align="center" rowspan="1" colspan="1">33.0 &#x000b1; 3.7</td><td align="center" rowspan="1" colspan="1">31.9 &#x000b1; 4.7 (21&#x02013;39)</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="center" rowspan="1" colspan="1">166 &#x000b1; 6</td><td align="center" rowspan="1" colspan="1">168 &#x000b1; 7</td><td align="center" rowspan="1" colspan="1">167 &#x000b1; 6 (160&#x02013;180)</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">89 &#x000b1; 20</td><td align="center" rowspan="1" colspan="1">81 &#x000b1; 8</td><td align="center" rowspan="1" colspan="1">85 &#x000b1; 15.5 (67&#x02013;125)</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m2)</td><td align="center" rowspan="1" colspan="1">32.2 &#x000b1; 6.3</td><td align="center" rowspan="1" colspan="1">28.1 &#x000b1; 3.2</td><td align="center" rowspan="1" colspan="1">30.1 &#x000b1; 5.4 (21.6&#x02013;41.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">135 &#x000b1; 20</td><td align="center" rowspan="1" colspan="1">137 &#x000b1; 14</td><td align="center" rowspan="1" colspan="1">136 &#x000b1; 17 (104&#x02013;168)</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">83 &#x000b1; 9</td><td align="center" rowspan="1" colspan="1">80 &#x000b1; 13</td><td align="center" rowspan="1" colspan="1">81 &#x000b1; 11 (62&#x02013;105)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean arterial pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">102 &#x000b1; 11</td><td align="center" rowspan="1" colspan="1">101 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1">101 &#x000b1; 11 (82&#x02013;122)</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart rate (bpm)</td><td align="center" rowspan="1" colspan="1">95 &#x000b1; 18</td><td align="center" rowspan="1" colspan="1">89 &#x000b1; 21</td><td align="center" rowspan="1" colspan="1">92 &#x000b1; 19 (59&#x02013;132)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke volume (ml)</td><td align="center" rowspan="1" colspan="1">97 &#x000b1; 21</td><td align="center" rowspan="1" colspan="1">105 &#x000b1; 20</td><td align="center" rowspan="1" colspan="1">101 &#x000b1; 20 (59&#x02013;149)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiac output (L/min)</td><td align="center" rowspan="1" colspan="1">8.9 &#x000b1; 1.1</td><td align="center" rowspan="1" colspan="1">9.0 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">8.9 &#x000b1; 1.6 (5.7&#x02013;13.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Total peripheral resistance (dyn s cm<sup>&#x02212;5</sup>)</td><td align="center" rowspan="1" colspan="1">933 &#x000b1; 162</td><td align="center" rowspan="1" colspan="1">946 &#x000b1; 262</td><td align="center" rowspan="1" colspan="1">940 &#x000b1; 213 (570&#x02013;1530)</td></tr><tr><td align="left" rowspan="1" colspan="1">Fetal heart rate (bpm)</td><td align="center" rowspan="1" colspan="1">138 &#x000b1; 9</td><td align="center" rowspan="1" colspan="1">137 &#x000b1; 9</td><td align="center" rowspan="1" colspan="1">138 &#x000b1; 9 (120&#x02013;150)</td></tr><tr><td align="left" rowspan="1" colspan="1">Frontal lobe oxygenation (%)</td><td align="center" rowspan="1" colspan="1">67 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1">64 &#x000b1; 7</td><td align="center" rowspan="1" colspan="1">66 &#x000b1; 8 (56&#x02013;91)</td></tr></tbody></table><table-wrap-foot><p>Values are means &#x000b1; SD. (range: minimum and maximum).</p></table-wrap-foot></table-wrap></sec><sec><title>Frontal lobe oxygenation</title><p>In patients allocated to administration of phenylephrine ScO<sub>2</sub> decreased by &#x02212;8.6 &#x000b1; 2.8% while in patients randomized to infusion of ephedrine, ScO<sub>2</sub> was not affected (+2.1 &#x000b1; 2.8%). Comparing the values determined in the two groups, the difference in ScO<sub>2</sub> was 10.7% (95% CI 2.8&#x02013;18.7%, <italic>p</italic> = 0.0106: Table <xref ref-type="table" rid="T2">2</xref>, Figure <xref ref-type="fig" rid="F2">2</xref>). Whereas ScO<sub>2</sub> was reduced from baseline in the phenylephrine group (<italic>p</italic> = 0.005), this was not the case with the administration of ephedrine (<italic>p</italic> = 0.4657).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p><bold>Change in outcomes from baseline on average during 60 min trial period, in patients randomized to either ephedrine or phenylephrine</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"><bold>(<bold><italic>n</italic></bold> = <bold>12</bold>) Ephedrine</bold></th><th align="center" rowspan="1" colspan="1"><bold>(<bold><italic>n</italic></bold> = <bold>12</bold>) Phenylephrine</bold></th><th align="center" rowspan="1" colspan="1"><bold>Difference (95% CI)</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>p</italic>-Value</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Frontal lobe oxygenation (%)</td><td align="center" rowspan="1" colspan="1">2.1 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">&#x02212;8.6 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">10.7 (2.8&#x02013;18.7)</td><td align="center" rowspan="1" colspan="1">0.0106</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">&#x02212;19 &#x000b1; 5</td><td align="center" rowspan="1" colspan="1">&#x02212;16 &#x000b1; 5</td><td align="center" rowspan="1" colspan="1">&#x02212;3 (&#x02212;17 to 11)</td><td align="center" rowspan="1" colspan="1">0.6329</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">&#x02212;17 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1">&#x02212;14 &#x000b1; 2</td><td align="center" rowspan="1" colspan="1">&#x02212;3 (&#x02212;10 to 3)</td><td align="center" rowspan="1" colspan="1">0.3093</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg)</td><td align="center" rowspan="1" colspan="1">&#x02212;20 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1">&#x02212;14 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1">&#x02212;6 (&#x02212;15 to 3)</td><td align="center" rowspan="1" colspan="1">0.1904</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart rate (bpm)</td><td align="center" rowspan="1" colspan="1">3 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1">&#x02212;11 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1">14 (5&#x02013;23)</td><td align="center" rowspan="1" colspan="1">0.0053</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke volume (ml)</td><td align="center" rowspan="1" colspan="1">4.4 &#x000b1; 5.0</td><td align="center" rowspan="1" colspan="1">9.7 &#x000b1; 4.8</td><td align="center" rowspan="1" colspan="1">&#x02212;5.3 (&#x02212;18.9 to 8.3)</td><td align="center" rowspan="1" colspan="1">0.4299</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiac output (L/min)</td><td align="center" rowspan="1" colspan="1">0.85 &#x000b1; 0.39</td><td align="center" rowspan="1" colspan="1">&#x02212;0.12 &#x000b1; 0.38</td><td align="center" rowspan="1" colspan="1">0.97 (&#x02212;0.08 to 2.02)</td><td align="center" rowspan="1" colspan="1">0.0683</td></tr><tr><td align="left" rowspan="1" colspan="1">TPR (dyn s cm<sup>&#x02212;5</sup>)</td><td align="center" rowspan="1" colspan="1">&#x02212;232 &#x000b1; 42</td><td align="center" rowspan="1" colspan="1">&#x02212;129 &#x000b1; 41</td><td align="center" rowspan="1" colspan="1">&#x02212;103 (214 to 8)</td><td align="center" rowspan="1" colspan="1">0.0684</td></tr><tr><td align="left" rowspan="1" colspan="1">Fetal heart rate (bpm)</td><td align="center" rowspan="1" colspan="1">19 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1">18 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1">1 (&#x02212;6 to 9)</td><td align="center" rowspan="1" colspan="1">0.7441</td></tr></tbody></table><table-wrap-foot><p>Presented are the ephedrine and phenylephrine group with values in means &#x000b1; SE (standard error) and differences in mean changes (95% CI). Values for frontal lobe oxygenation (ScO<sub><italic>2</italic></sub>) are changes in percent.</p></table-wrap-foot></table-wrap><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Change in ScO<sub>2</sub> from baseline</bold>. Changes in frontal lobe oxygenation (ScO2; % from baseline) during caesarean section with spinal anesthesia. Patients received either phenylephrine (<italic>n</italic> = 12; open circles) or ephedrine (<italic>n</italic> = 12; black circles).</p></caption><graphic xlink:href="fphys-05-00081-g0002"/></fig></sec><sec><title>Cardiovascular effects</title><p>Phenylephrine (&#x02212;14 &#x000b1; 3 mmHg) and ephedrine (&#x02212;20 &#x000b1; 3 mmHg) were equally effective in maintaining MAP (Figure <xref ref-type="fig" rid="F3">3</xref>) with a group mean difference of 6 mmHg (95% CI &#x02212;15 to 3, <italic>p</italic> = 0.1904). Similar results were obtained for DBP and SBP (Table <xref ref-type="table" rid="T2">2</xref>). The maternal HR was maintained with ephedrine (+3 &#x000b1; 3 bpm) but decreased with phenylephrine (&#x02212;11 &#x000b1; 3 bpm); difference 14 (95% CI 5&#x02013;23, <italic>p</italic> = 0.0053) bpm. SV appeared to increase both with phenylephrine (9.7 &#x000b1; 4.8 ml) and with ephedrine (4.4 &#x000b1; 5.0 ml), but this difference was not significant: &#x02212;5.3 ml (95% CI &#x02212;18.9 to 8.3, <italic>p</italic> = 0.4299). In the ephedrine group CO increased by 0.9 &#x000b1; 0.4 l/min, while in the phenylephrine group CO was stable (&#x02212;0.1 &#x000b1; 0.4 l/min); 95% CI &#x02212;0.08 to 2.02, <italic>p</italic> = 0.0683). There was a tendency for TPR to be lower in the ephedrine group compared with the phenylephrine group (&#x02212;232 &#x000b1; 42 vs. &#x02212;129 &#x000b1; 41) dyn s cm<sup>&#x02212;5</sup> (<italic>p</italic> = 0.0684).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Change in mean arterial pressure from baseline</bold>. Changes in mean arterial blood pressure (MAP) from baseline (mmHg) during caesarean section with spinal anesthesia. Patients received either phenylephrine (<italic>n</italic> = 12; open circles) or ephedrine (<italic>n</italic> = 12; black circles).</p></caption><graphic xlink:href="fphys-05-00081-g0003"/></fig></sec><sec><title>Fetal variables</title><p>The difference in fetal heart rate between the ephedrine and phenylephrine group was 1 bpm (95% CI &#x02212;6 to 9, <italic>p</italic> = 0.7441); for ephedrine +19 &#x000b1; 3 vs. +18 &#x000b1; 3 bpm for phenylephrine (Table <xref ref-type="table" rid="T2">2</xref>, Figure <xref ref-type="fig" rid="F4">4</xref>). When compared to baseline both ephedrine (<italic>p</italic> &#x0003c; 0.005) and phenylephrine (<italic>p</italic> &#x0003c; 0.005) increased fetal heart rate. All Apgar scores were = 8 one minute after delivery and increased to 10 after 5 min in both groups. There was a difference (<italic>p</italic> = 0.0223) in regard to the umbilical venous base excess: &#x02212;1.0 (95% CI &#x02212;0.86 to &#x02212;0.14) mM and arterial umbilical lactate was higher in the ephedrine than in the phenylephrine group: 0.50 (95% CI 0.09&#x02013;0.91) mM, <italic>p</italic> = 0.017, while no differences were observed in any of the other umbilical cord blood variables assessed (Table <xref ref-type="table" rid="T3">3</xref>).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Foetal heart rate</bold>. Change in fetal heart rate (bpm) after induction (2.5&#x02013;5 min), before surgery (7.5&#x02013;17.5 min), after delivery (12.5&#x02013;27.5 min) in two groups of 12 patients undergoing spinal anesthesia for caesarean section and receiving either phenylephrine (open circles) or ephedrine (black circles).</p></caption><graphic xlink:href="fphys-05-00081-g0004"/></fig><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><bold>Umbilical cord blood analysis</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Variable</bold></th><th align="center" rowspan="1" colspan="1"><bold>Ephedrine</bold></th><th align="center" rowspan="1" colspan="1"><bold>Phenylephrine</bold></th><th align="center" rowspan="1" colspan="1"><bold>Difference between groups (95% CI)</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>p</italic>-Value</bold></th></tr></thead><tbody><tr><td align="left" colspan="5" rowspan="1"><bold>UMBILICAL ARTERIAL</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">pH</td><td align="center" rowspan="1" colspan="1">7.29 &#x000b1; 0.08</td><td align="center" rowspan="1" colspan="1">7.31 &#x000b1; 0.05</td><td align="center" rowspan="1" colspan="1">&#x02212;0.02 (&#x02212;0.07 to 0.04)</td><td align="center" rowspan="1" colspan="1">0.4699</td></tr><tr><td align="left" rowspan="1" colspan="1">Pco2; kPa</td><td align="center" rowspan="1" colspan="1">7.36 &#x000b1; 1.63</td><td align="center" rowspan="1" colspan="1">6.98 &#x000b1; 0.77</td><td align="center" rowspan="1" colspan="1">0.38 (&#x02212;0.72 to 1.48)</td><td align="center" rowspan="1" colspan="1">0.4793</td></tr><tr><td align="left" rowspan="1" colspan="1">Base excess (mM)**</td><td align="center" rowspan="1" colspan="1">&#x02212;0.3 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">0.6 &#x000b1; 1.6</td><td align="center" rowspan="1" colspan="1">0.9 (&#x02212;3.0 to 1.1)</td><td align="center" rowspan="1" colspan="1">0.3414</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mM)</td><td align="center" rowspan="1" colspan="1">2.4 [2.2 to 3.4]</td><td align="center" rowspan="1" colspan="1">1.9 [1.5&#x02013;2.2]</td><td align="center" rowspan="1" colspan="1">0.50 (0,09&#x02013;0.91)<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td><td align="center" rowspan="1" colspan="1">0.0170</td></tr><tr><td align="left" colspan="5" rowspan="1"><bold>UMBILICAL VENOUS</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">pH</td><td align="center" rowspan="1" colspan="1">7.37 &#x000b1; 0.06</td><td align="center" rowspan="1" colspan="1">7.37 &#x000b1; 0.04</td><td align="center" rowspan="1" colspan="1">0.00 (&#x02212;0.04 to 0.04)</td><td align="center" rowspan="1" colspan="1">0.9350</td></tr><tr><td align="left" rowspan="1" colspan="1">Pco2; kPa</td><td align="center" rowspan="1" colspan="1">5.58 &#x000b1; 1.00</td><td align="center" rowspan="1" colspan="1">5.95 &#x000b1; 0.60</td><td align="center" rowspan="1" colspan="1">&#x02212;0.37 (&#x02212;1.10 to 0.37)</td><td align="center" rowspan="1" colspan="1">0.3083</td></tr><tr><td align="left" rowspan="1" colspan="1">Base excess (mM)</td><td align="center" rowspan="1" colspan="1">&#x02212;1.0 [&#x02212;2.6 to &#x02212;0.5]</td><td align="center" rowspan="1" colspan="1">0.0 [&#x02212;0.1 to 0.3]</td><td align="center" rowspan="1" colspan="1">&#x02212;1.0 (&#x02212;0.86 to &#x02212;0.14)<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td><td align="center" rowspan="1" colspan="1">0.0223</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mM)</td><td align="center" rowspan="1" colspan="1">2.1 [1.4&#x02013;2.6]</td><td align="center" rowspan="1" colspan="1">1.9 [1.5&#x02013;2.2]</td><td align="center" rowspan="1" colspan="1">0.20 (&#x02212;0,09 to 0.49)<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td><td align="center" rowspan="1" colspan="1">0.1738</td></tr></tbody></table><table-wrap-foot><p>Values are mean &#x000b1; SD and differences in mean changes (95% CI). Exceptions are arterial and venous blood lactate, venous base excess which is shown as median with interquartile range (IQR) in square brackets.</p><fn id="TN1"><label>*</label><p>Median difference.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Operative results</title><p>The time between intra-thecal injection and start of surgery [difference 0.0 (95% CI &#x02212;2.8 to 2.8) min, <italic>p</italic> = 0.9976)] and between intra-thecal injection and delivery [difference 0.2 (95% CI 0.2 to 3.2) min, <italic>p</italic> = 0.9106)] were similar for the ephedrine and the phenylephrine groups (Table <xref ref-type="table" rid="T4">4</xref>). The amount of i.v. saline was also equal between the two groups: 63 ml (95% CI &#x02212;259 to 134, <italic>p</italic> = 0.0515) and there was no difference in the blood loss (100 ml (95% CI of difference &#x02212;275 to 475), <italic>p</italic> = 0.601).</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p><bold>Surgical times and intravenous fluid</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Variable</bold></th><th align="center" rowspan="1" colspan="1"><bold>Ephedrine</bold></th><th align="center" rowspan="1" colspan="1"><bold>Phenylephrine</bold></th><th align="center" rowspan="1" colspan="1"><bold>Difference between groups (95% CI)</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>p</italic>-value</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Induction to incision (min)</td><td align="center" rowspan="1" colspan="1">13.3 &#x000b1; 3.3</td><td align="center" rowspan="1" colspan="1">13.3 &#x000b1; 3.3</td><td align="center" rowspan="1" colspan="1">0.0 (&#x02212;2.8 to 2.8)</td><td align="center" rowspan="1" colspan="1">0.9976</td></tr><tr><td align="left" rowspan="1" colspan="1">Induction to delivery (min)</td><td align="center" rowspan="1" colspan="1">17.5 &#x000b1; 3.2</td><td align="center" rowspan="1" colspan="1">17.3 &#x000b1; 3.9</td><td align="center" rowspan="1" colspan="1">0.2 (&#x02212;2.8 to 3.2)</td><td align="center" rowspan="1" colspan="1">0.9106</td></tr><tr><td align="left" rowspan="1" colspan="1">Total intravenous fluid (ml)</td><td align="center" rowspan="1" colspan="1">904 &#x000b1; 254</td><td align="center" rowspan="1" colspan="1">967 &#x000b1; 206</td><td align="center" rowspan="1" colspan="1">&#x02212;63 (&#x02212;259 to 134)</td><td align="center" rowspan="1" colspan="1">0.5153</td></tr></tbody></table><table-wrap-foot><p>Values are mean &#x000b1; SD and differences in mean changes (95% CI).</p></table-wrap-foot></table-wrap></sec><sec><title>Vasopressor dose</title><p>The ephedrine dose per minute was 1.7 mg (1.3&#x02013;2) range 0.7&#x02013;5.9 mg and of phenylephrine 1.38 mg (0.91&#x02013;1.55) range 0.57&#x02013;1.82 mg. No patient was treated with both phenylephrine and ephedrine.</p><p>Further monitoring (not reported) included pulse oximetry, ECG, non-invasive blood pressure on the right arm after initiation of saline administration and continued until the patient was transferred to the postoperative observation unit (no abnormal values were noted).</p></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>The present study confirmed that phenylephrine and ephedrine are equally effective in maintaining MAP in patients undergoing caesarean section with spinal anesthesia. The new finding is that in patients undergoing spinal anesthesia, the use of the ephedrine, capable of activating both &#x003b1; and &#x003b2; adrenergic receptors, preserves the near infrared-determined frontal lobe oxygenation (ScO<sub>2</sub>) while ScO<sub>2</sub> was reduced in patients allocated to administration of phenylephrine, a selective &#x003b1;-adrenergic receptor agonist. We considered that women going through caesarean section during spinal anesthesia might be hypovolemic because of compromised venous return and that phenylephrine therefore could support cardiac output and in turn cerebral oxygenation as expressed by ScO<sub>2</sub>. In contrast to our hypothesis, however, phenylephrine did not increase CO and maybe therefore reduced ScO<sub>2</sub>. In other word, with the established routine for maintaining the circulation during caesarean section during spinal anesthesia, CO in response to administration of phenylephrine indicated that the patients were maintained &#x0201c;normovolemic.&#x0201d; Furthermore, only ephedrine maintained HR and the two drugs elicited an equal almost 20 bpm increase in fetal heart rate.</p><p>Spinal anesthesia influences MAP because of sympathetic blockade and during caesarean section inferior caval compression may reduce venous return to the heart and thus CO (Cyna et al., <xref rid="B5" ref-type="bibr">2006</xref>) During caesarean section hypotension is considered when maternal SBP decreases by 20&#x02013;30% or decreases to less than 90&#x02013;100 mmHg (Saravanan et al., <xref rid="B36" ref-type="bibr">2006</xref>; Ngan Kee et al., <xref rid="B27" ref-type="bibr">2008a</xref>) although we acknowledge that the lower limit of cerebral autoregulation has been challenged (Lucas et al., <xref rid="B20" ref-type="bibr">2010</xref>; Tan, <xref rid="B40" ref-type="bibr">2012</xref>). Thus, MAP did not fall to what is considered to be the lower limit of cerebral autoregulation (Paulson et al., <xref rid="B34" ref-type="bibr">1990</xref>) and the patients were not expected to be exposed to cerebral hypoperfusion and a reduction in ScO<sub>2</sub>. However, administration of phenylephrine led to a ~9% reduction in ScO<sub>2</sub> (Figure <xref ref-type="fig" rid="F2">2</xref>, Table <xref ref-type="table" rid="T2">2</xref>). A decrease in MAP to below ~80 mmHg, as provoked for example during head-up tilt, reduces cerebral blood flow and ScO<sub>2</sub> because of a reduced central blood volume and CO (Madsen et al., <xref rid="B21" ref-type="bibr">1998</xref>) However, whether or not a balance exists between cerebral oxygen supply and demand during anesthesia-induced hypotension remains unknown (Meng et al., <xref rid="B24" ref-type="bibr">2013</xref>).</p><p>A 10&#x02013;15% reduction in ScO<sub>2</sub> and a 50% reduction in middle cerebral artery mean flow velocity are associated with pre-syncopal symptoms (Kurihara et al., <xref rid="B16" ref-type="bibr">2007</xref>) The 9% reduction in ScO<sub>2</sub> in response to administration of phenylephrine during spinal anesthesia for elective caesarean section approaches that level and could thus represent clinically important cerebral hypoperfusion (Hunt et al., <xref rid="B11" ref-type="bibr">2006</xref>; Suzuki et al., <xref rid="B39" ref-type="bibr">2008</xref>; Nissen et al., <xref rid="B31" ref-type="bibr">2009b</xref>). On the other hand, the patients were awake and able to report hypotension-associated symptoms (nausea, vomiting or dizziness), but no complaints were expressed regardless of the NIRS value. It is possible that the 9% reduction in ScO<sub>2</sub> following the administration of phenylephrine reflects contamination of the NIRS signal from extracranial tissue (Davie and Grocott, <xref rid="B7" ref-type="bibr">2012</xref>).</p><p>There was no difference in fetal HR among groups of patients and neonatal outcome was similar, although there were small but probably clinically unimportant differences in regard to umbilical arterial lactate and venous base excess. Ephedrine could increase fetal HR due to &#x003b2;-adrenergic stimulation, when or if it crosses placenta inducing fetal acidaemia (LaPorta et al., <xref rid="B18" ref-type="bibr">1995</xref>) The impact of ephedrine on arterial lactate and venous base excess could be related to an effect on uteroplacental or feto-placental circulation (McGrath et al., <xref rid="B22" ref-type="bibr">1994</xref>; LaPorta et al., <xref rid="B18" ref-type="bibr">1995</xref>).</p><p>We recognize that this evaluation is not a blinded randomized controlled trial and further that it is a limitation to the study that both physicians and nurses expected that ephedrine would increase maternal heart rate and therefore potentially influenced by that expectation.We estimated blood pressure 2.5 min after initiation of anesthesia and with the use of vasopressor this considered as a long time and could represent a limitation of the study.</p><p>There were some difficulties in using Nexfin to estimate cardiovascular variables during caesarean section when the patients moved due to anxiety. Also, Modelflow may not be provide an accurate CO (Remmen et al., <xref rid="B35" ref-type="bibr">2002</xref>) and calibration by thermodilution (Jansen et al., <xref rid="B13" ref-type="bibr">2001</xref>) or by the Fick method (van Lieshout et al., <xref rid="B41" ref-type="bibr">2001</xref>) may be in need. However, for tracking changes in CO the Nexfin has been successfully validated against a thermodilution estimate during a deliberate reduction in central blood volume induced by standing up in healthy subjects (Harms et al., <xref rid="B10" ref-type="bibr">1999</xref>) during cardiac surgery (Jansen et al., <xref rid="B13" ref-type="bibr">2001</xref>) in intensive care medicine (Jellema et al., <xref rid="B14" ref-type="bibr">1999</xref>) and during liver transplantation (Nissen et al., <xref rid="B32" ref-type="bibr">2009c</xref>).</p><p>Phenylephrine preserved MAP and reduced HR and maintained CO with a slight increase in SV that was 5 ml higher than the increase in the subjects receiving ephedrine. Phenylephrine may increase cardiac afterload to an extent that SV and CO decrease. On the other hand, an increase in vascular tone can increase venous return and thereby cardiac preload, SV and CO during hypovolemia as demonstrated in anesthetized pigs (Cannesson et al., <xref rid="B3" ref-type="bibr">2012</xref>) Meng et al. found an increase in SV and CO after administration of phenylephrine using pulsewave analysis by Vigileo-FloTrac in non-pregnant patients, but the increases were not confirmed with the use of a trans-esophageal Doppler apparatus (Meng et al., <xref rid="B25" ref-type="bibr">2011b</xref>). Also an increase in SV in response to administration of phenylephrine is supported by Doherty et al. who used a CO monitor based on bi-reactance technology (Doherty et al., <xref rid="B8" ref-type="bibr">2012</xref>) and by Dyer et al. using a LiDCOplus monitor (Dyer et al., <xref rid="B9" ref-type="bibr">2009</xref>).</p><p>Another limitation of this trial was that we measured ScO<sub>2</sub> and not cerebral blood flow, but parallel variation between middle cerebral artery mean flow velocity in basal cerebral arteries and ScO<sub>2</sub> is reported (Ide et al., <xref rid="B12" ref-type="bibr">1999</xref>; Yoshitani et al., <xref rid="B44" ref-type="bibr">2007</xref>; Steiner et al., <xref rid="B38" ref-type="bibr">2009</xref>) Furthermore, determination of internal jugular venous oxygen saturation could validate if the data obtained by NIRS are representative for the whole brain (Kim et al., <xref rid="B15" ref-type="bibr">2000</xref>).</p><p>Three different NIRS approaches can be implemented: (1) Continuous wave (CW), (2) Frequency-domain (FD), and (3) time domain technology (TD). An approximate 3&#x02013;4% decrease in ScO<sub>2</sub> is reported after treatment with phenylephrine with the use of FD (Meng et al., <xref rid="B23" ref-type="bibr">2011a</xref>), compared with the 9% decrease in this evaluation while others (Nissen et al., <xref rid="B29" ref-type="bibr">2010</xref>; Ogoh et al., <xref rid="B33" ref-type="bibr">2011</xref>) find an approximate decrease by 14% using CW. With commercial CW monitors there is a variation in the ability to estimate ScO<sub>2</sub> (Davie and Grocott, <xref rid="B7" ref-type="bibr">2012</xref>).</p></sec><sec sec-type="conclusion" id="s5"><title>Conclusion</title><p>This study confirmed that infusion of phenylephrine and ephedrine are equally effective for sustaining blood pressure during elective caesarean section with spinal anesthesia. Phenylephrine, however, reduced ScO<sub>2</sub> and maternal heart rate when compared to ephedrine but the two drugs induced an equal increase in fetal heart rate.</p></sec><sec><title>Author's contribution</title><p>Peter Nissen, Niels H. Secher, Henning B. Nielsen, Kim Z. Rokamp, and Visti T. Foss conceived and designed the trial protocol. Visti T. Foss procured the project funding in cooperation with Department of Anaesthesia, N&#x000e6;stved Hospital, Denmark. Visti T. Foss and Kim Z. Rokamp contributed to clinical screening and recruitment of patients. Visti T. Fossand Kim Z. Rokamp handled the cooperation with the Good Clinical Practice (GCP) unit at the University of Copenhagen with VF as primary investigator and Kim Z. Rokamp as sponsor. Visti T. Foss and Robin Christensen did the statistical analyses. Visti T. Foss, Robin Christensen, Niels H. Secher and Kim Z. Rokamp drafted the manuscript, and Peter Nissen and Henning B. Nielsen contributed to the manuscript. All authors read and approved the final manuscript. Visti T. Foss and Kim Z. Rokamp accept full responsibility for this work and act as guarantors for the study.</p><sec><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>The authors wish to thank Malene L. Pedersen M.D. for the recruitment of patients. In addition the authors thank the midwives of N&#x000e6;stved Hospital, Denmark for their assistance and cooperation. For the use of INVOS 3100 cerebral oxymeter we thank Malene Brorsen, Covidien, Denmark. For proofreading the manuscript, we thank James Fisher, School of Sport and Exercise Sciences, University of Birmingham, UK.</p></ack><sec><title>Funding</title><p>This work was supported by Department of Anaesthesia, N&#x000e6;stved Hospital, Denmark and by the Copenhagen Muscle Research Center. The Musculoskeletal Statistics Unit, The Parker Institute, is supported by the Oak Foundation. The Rigshospitalet research foundation supported Henning B. Nielsen.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berlac</surname><given-names>P. A.</given-names></name><name><surname>Rasmussen</surname><given-names>Y. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Per-operative cerebral near-infrared spectroscopy (NIRS) predicts maternal hypotension during elective caesarean delivery in spinal anaesthesia</article-title>. <source>Int. J. Obstet. Anesth</source>. <volume>14</volume>, <fpage>26</fpage>&#x02013;<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijoa.2004.06.003</pub-id><pub-id pub-id-type="pmid">15627535</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogert</surname><given-names>L. W.</given-names></name><name><surname>van Lieshout</surname><given-names>J. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Non-invasive pulsatile arterial pressure and stroke volume changes from the human finger</article-title>. <source>Exp. Physiol</source>. <volume>90</volume>, <fpage>437</fpage>&#x02013;<lpage>446</lpage>
<pub-id pub-id-type="doi">10.1113/expphysiol.2005.030262</pub-id><pub-id pub-id-type="pmid">15802289</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannesson</surname><given-names>M.</given-names></name><name><surname>Zhongping</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Vu</surname><given-names>T. Q.</given-names></name><name><surname>Hatib</surname><given-names>F.</given-names></name></person-group> (<year>2012</year>). <article-title>Effects of phenylephrine on cardiac output and venous return depend on the position of the heart on the Frank-Starling relationship</article-title>. <source>J. Appl. Physiol</source>. <volume>113</volume>, <fpage>281</fpage>&#x02013;<lpage>289</lpage>
<pub-id pub-id-type="doi">10.1152/japplphysiol.00126.2012</pub-id><pub-id pub-id-type="pmid">22556399</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J.</given-names></name><name><surname>Wolf</surname><given-names>M.</given-names></name><name><surname>Toronov</surname><given-names>V.</given-names></name><name><surname>Wolf</surname><given-names>U.</given-names></name><name><surname>Polzonetti</surname><given-names>C.</given-names></name><name><surname>Hueber</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Noninvasive determination of the optical properties of adult brain: near-infrared spectroscopy approach</article-title>. <source>J. Biomed. Opt</source>. <volume>9</volume>, <fpage>221</fpage>&#x02013;<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1117/1.1628242</pub-id><pub-id pub-id-type="pmid">14715077</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cyna</surname><given-names>A. M.</given-names></name><name><surname>Andrew</surname><given-names>M.</given-names></name><name><surname>Emmett</surname><given-names>R. S.</given-names></name><name><surname>Middleton</surname><given-names>P.</given-names></name><name><surname>Simmons</surname><given-names>S. W.</given-names></name></person-group> (<year>2006</year>). <article-title>Techniques for preventing hypotension during spinal anaesthesia for caesarean section</article-title>. <source>Cochrane Database Syst. Rev</source>. <volume>4</volume>:<fpage>CD002251</fpage>
<pub-id pub-id-type="doi">10.1002/14651858.CD002251.pub2</pub-id><pub-id pub-id-type="pmid">17054153</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Mukhopadhyay</surname><given-names>S.</given-names></name><name><surname>Mandal</surname><given-names>M.</given-names></name><name><surname>Mandal</surname><given-names>S.</given-names></name><name><surname>Basu</surname><given-names>S. R.</given-names></name></person-group> (<year>2011</year>). <article-title>A comparative study of infusions of phenylephrine, ephedrine and phenylephrine plus ephedrine on maternal haemodynamics in elective caesarean section</article-title>. <source>Indian J. Anaesth</source>. <volume>55</volume>, <fpage>578</fpage>&#x02013;<lpage>583</lpage>
<pub-id pub-id-type="doi">10.4103/0019-5049.90612</pub-id><pub-id pub-id-type="pmid">22223901</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davie</surname><given-names>S. N.</given-names></name><name><surname>Grocott</surname><given-names>H. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Impact of extracranial contamination on regional cerebral oxygen saturation: a comparison of three cerebral oximetry technologies</article-title>. <source>Anesthesiology</source>
<volume>116</volume>, <fpage>834</fpage>&#x02013;<lpage>840</lpage>
<pub-id pub-id-type="doi">10.1097/ALN.0b013e31824c00d7</pub-id><pub-id pub-id-type="pmid">22343469</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>A.</given-names></name><name><surname>Ohashi</surname><given-names>Y.</given-names></name><name><surname>Downey</surname><given-names>K.</given-names></name><name><surname>Carvalho</surname><given-names>J. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Phenylephrine infusion versus bolus regimens during cesarean delivery under spinal anesthesia: a double-blind randomized clinical trial to assess hemodynamic changes</article-title>. <source>Anesth. Analg</source>. <volume>115</volume>, <fpage>1343</fpage>&#x02013;<lpage>1350</lpage>
<pub-id pub-id-type="doi">10.1213/ANE.0b013e31826ac3db</pub-id><pub-id pub-id-type="pmid">23011562</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyer</surname><given-names>R. A.</given-names></name><name><surname>Reed</surname><given-names>A. R.</given-names></name><name><surname>van Dyk</surname><given-names>D.</given-names></name><name><surname>Arcache</surname><given-names>M. J.</given-names></name><name><surname>Hodges</surname><given-names>O.</given-names></name><name><surname>Lombard</surname><given-names>C. J.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Hemodynamic effects of ephedrine, phenylephrine, and the coadministration of phenylephrine with oxytocin during spinal anesthesia for elective cesarean delivery</article-title>. <source>Anesthesiology</source>
<volume>111</volume>, <fpage>753</fpage>&#x02013;<lpage>765</lpage>
<pub-id pub-id-type="doi">10.1097/ALN.0b013e3181b437e0</pub-id><pub-id pub-id-type="pmid">19741494</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harms</surname><given-names>M. P.</given-names></name><name><surname>Wesseling</surname><given-names>K. H.</given-names></name><name><surname>Pott</surname><given-names>F.</given-names></name><name><surname>Jenstrup</surname><given-names>M.</given-names></name><name><surname>Van Goudoever</surname><given-names>J.</given-names></name><name><surname>Secher</surname><given-names>N. H.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Continuous stroke volume monitoring by modelling flow from non-invasive measurement of arterial pressure in humans under orthostatic stress</article-title>. <source>Clin. Sci</source>. <volume>97</volume>, <fpage>291</fpage>&#x02013;<lpage>301</lpage>
<pub-id pub-id-type="doi">10.1042/CS19990061</pub-id><pub-id pub-id-type="pmid">10464054</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>K.</given-names></name><name><surname>Tachtsidis</surname><given-names>I.</given-names></name><name><surname>Bleasdale-Barr</surname><given-names>K.</given-names></name><name><surname>Elwell</surname><given-names>C.</given-names></name><name><surname>Mathias</surname><given-names>C.</given-names></name><name><surname>Smith</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Changes in cerebral oxygenation and haemodynamics during postural blood pressure changes in patients with autonomic failure</article-title>. <source>Physiol. Meas</source>. <volume>27</volume>, <fpage>777</fpage>&#x02013;<lpage>785</lpage>
<pub-id pub-id-type="doi">10.1088/0967-3334/27/9/002</pub-id><pub-id pub-id-type="pmid">16868345</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ide</surname><given-names>K.</given-names></name><name><surname>Horn</surname><given-names>A.</given-names></name><name><surname>Secher</surname><given-names>N. H.</given-names></name></person-group> (<year>1999</year>). <article-title>Cerebral metabolic response to submaximal exercise</article-title>. <source>J. Appl. Physiol</source>. <volume>87</volume>, <fpage>1604</fpage>&#x02013;<lpage>1608</lpage>
<pub-id pub-id-type="pmid">10562597</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname><given-names>J. R.</given-names></name><name><surname>Schreuder</surname><given-names>J. J.</given-names></name><name><surname>Mulier</surname><given-names>J. P.</given-names></name><name><surname>Smith</surname><given-names>N. T.</given-names></name><name><surname>Settels</surname><given-names>J. J.</given-names></name><name><surname>Wesseling</surname><given-names>K. H.</given-names></name></person-group> (<year>2001</year>). <article-title>A comparison of cardiac output derived from the arterial pressure wave against thermodilution in cardiac surgery patients</article-title>. <source>Br J Anaesth</source>. <volume>87</volume>, <fpage>212</fpage>&#x02013;<lpage>222</lpage>
<pub-id pub-id-type="doi">10.1093/bja/87.2.212</pub-id><pub-id pub-id-type="pmid">11493492</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jellema</surname><given-names>W. T.</given-names></name><name><surname>Wesseling</surname><given-names>K. H.</given-names></name><name><surname>Groeneveld</surname><given-names>A. B.</given-names></name><name><surname>Stoutenbeek</surname><given-names>C. P.</given-names></name><name><surname>Thijs</surname><given-names>L. G.</given-names></name><name><surname>van Lieshout</surname><given-names>J. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Continuous cardiac output in septic shock by simulating a model of the aortic input impedance: a comparison with bolus injection thermodilution</article-title>. <source>Anesthesiology</source>
<volume>90</volume>, <fpage>1317</fpage>&#x02013;<lpage>1328</lpage>
<pub-id pub-id-type="doi">10.1097/00000542-199905000-00016</pub-id><pub-id pub-id-type="pmid">10319780</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M. B.</given-names></name><name><surname>Ward</surname><given-names>D. S.</given-names></name><name><surname>Cartwright</surname><given-names>C. R.</given-names></name><name><surname>Kolano</surname><given-names>J.</given-names></name><name><surname>Chlebowski</surname><given-names>S.</given-names></name><name><surname>Henson</surname><given-names>L. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Estimation of jugular venous O2 saturation from cerebral oximetry or arterial O2 saturation during isocapnic hypoxia</article-title>. <source>J. Clin. Monit. Comput</source>. <volume>16</volume>, <fpage>191</fpage>&#x02013;<lpage>199</lpage>
<pub-id pub-id-type="doi">10.1023/A:1009940031063</pub-id><pub-id pub-id-type="pmid">12578103</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurihara</surname><given-names>K.</given-names></name><name><surname>Kikukawa</surname><given-names>A.</given-names></name><name><surname>Kobayashi</surname><given-names>A.</given-names></name><name><surname>Nakadate</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Frontal cortical oxygenation changes during gravity-induced loss of consciousness in humans: a near-infrared spatially resolved spectroscopic study</article-title>. <source>J. Appl. Physiol</source>. <volume>103</volume>, <fpage>1326</fpage>&#x02013;<lpage>1331</lpage>
<pub-id pub-id-type="doi">10.1152/japplphysiol.01191.2006</pub-id><pub-id pub-id-type="pmid">17641211</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langesaeter</surname><given-names>E.</given-names></name><name><surname>Rosseland</surname><given-names>L. A.</given-names></name><name><surname>Stubhaug</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Continuous invasive blood pressure and cardiac output monitoring during cesarean delivery: a randomized, double-blind comparison of low-dose versus high-dose spinal anesthesia with intravenous phenylephrine or placebo infusion</article-title>. <source>Anesthesiology</source>
<volume>109</volume>, <fpage>856</fpage>&#x02013;<lpage>863</lpage>
<pub-id pub-id-type="doi">10.1097/ALN.0b013e31818a401f</pub-id><pub-id pub-id-type="pmid">18946298</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaPorta</surname><given-names>R. F.</given-names></name><name><surname>Arthur</surname><given-names>G. R.</given-names></name><name><surname>Datta</surname><given-names>S.</given-names></name></person-group> (<year>1995</year>). <article-title>Phenylephrine in treating maternal hypotension due to spinal anaesthesia for caesarean delivery: effects on neonatal catecholamine concentrations, acid base status and Apgar scores</article-title>. <source>Acta Anaesthesiol. Scand</source>. <volume>39</volume>, <fpage>901</fpage>&#x02013;<lpage>915</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-6576.1995.tb04195.x</pub-id><pub-id pub-id-type="pmid">8848889</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Littell</surname><given-names>R. C.</given-names></name><name><surname>Pendergast</surname><given-names>J.</given-names></name><name><surname>Natarajan</surname><given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>Modelling covariance structure in the analysis of repeated measures data</article-title>. <source>Stat. Med</source>. <volume>19</volume>, <fpage>1793</fpage>&#x02013;<lpage>1819</lpage>
<pub-id pub-id-type="doi">10.1002/1097-0258(20000715)19:13&#x0003c;1793::AID-SIM482&#x0003e;3.3.CO;2-H</pub-id><pub-id pub-id-type="pmid">10861779</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>S. J.</given-names></name><name><surname>Tzeng</surname><given-names>Y. C.</given-names></name><name><surname>Galvin</surname><given-names>S. D.</given-names></name><name><surname>Thomas</surname><given-names>K. N.</given-names></name><name><surname>Ogoh</surname><given-names>S.</given-names></name><name><surname>Ainslie</surname><given-names>P. N.</given-names></name></person-group> (<year>2010</year>). <article-title>Influence of changes in blood pressure on cerebral perfusion and oxygenation</article-title>. <source>Hypertension</source>
<volume>55</volume>, <fpage>698</fpage>&#x02013;<lpage>705</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.109.146290</pub-id><pub-id pub-id-type="pmid">20083726</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>P.</given-names></name><name><surname>Olsen</surname><given-names>S. B.</given-names></name><name><surname>Nielsen</surname><given-names>H. B.</given-names></name><name><surname>Burcev</surname><given-names>I.</given-names></name><name><surname>Secher</surname><given-names>N. H.</given-names></name></person-group> (<year>1998</year>). <article-title>Near-infrared spectrophotometry determined brain oxygenation during fainting</article-title>. <source>Acta Physiol. Scand</source>. <volume>162</volume>, <fpage>501</fpage>&#x02013;<lpage>517</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-201X.1998.0308f.x</pub-id><pub-id pub-id-type="pmid">9597118</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>J. M.</given-names></name><name><surname>Chestnut</surname><given-names>D. H.</given-names></name><name><surname>Vincent</surname><given-names>R. D.</given-names></name><name><surname>DeBruyn</surname><given-names>C. S.</given-names></name><name><surname>Atkins</surname><given-names>B. L.</given-names></name><name><surname>Poduska</surname><given-names>D. J.</given-names></name></person-group> (<year>1994</year>). <article-title>Ephedrine remains the vasopressor of choice for treatment of hypotension during ritodrine infusion and epidural anesthesia</article-title>. <source>Anesthesiology</source>
<volume>80</volume>, <fpage>1073</fpage>&#x02013;<lpage>1081</lpage>
<pub-id pub-id-type="doi">10.1097/00000542-199405000-00016</pub-id><pub-id pub-id-type="pmid">8017645</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Cannesson</surname><given-names>M.</given-names></name><name><surname>Alexander</surname><given-names>B. S.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Kain</surname><given-names>Z. N.</given-names></name><name><surname>Cerussi</surname><given-names>A. E.</given-names></name><etal/></person-group> (<year>2011a</year>). <article-title>Effects of phenylephrine and ephedrine bolus treatment on cerebral oxygenation in anaesthetized patients</article-title>. <source>Br. J. Anaesth</source>. <volume>107</volume>, <fpage>209</fpage>&#x02013;<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1093/bja/aer150</pub-id><pub-id pub-id-type="pmid">21642644</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Gelb</surname><given-names>A. W.</given-names></name><name><surname>McDonagh</surname><given-names>D. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Changes in cerebral tissue oxygen saturation during anaesthetic-induced hypotension: an interpretation based on neurovascular coupling and cerebral autoregulation</article-title>. <source>Anaesthesia</source>
<volume>68</volume>, <fpage>736</fpage>&#x02013;<lpage>441</lpage>
<pub-id pub-id-type="doi">10.1111/anae.12254</pub-id><pub-id pub-id-type="pmid">23614880</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Tran</surname><given-names>N. P.</given-names></name><name><surname>Alexander</surname><given-names>B. S.</given-names></name><name><surname>Laning</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Kain</surname><given-names>Z. N.</given-names></name><etal/></person-group> (<year>2011b</year>). <article-title>The impact of phenylephrine, ephedrine, and increased preload on third-generation Vigileo-FloTrac and esophageal doppler cardiac output measurements</article-title>. <source>Anesth. Analg</source>. <volume>113</volume>, <fpage>751</fpage>&#x02013;<lpage>757</lpage>
<pub-id pub-id-type="doi">10.1213/ANE.0b013e31822649fb</pub-id><pub-id pub-id-type="pmid">21821516</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercier</surname><given-names>F. J.</given-names></name><name><surname>Riley</surname><given-names>E. T.</given-names></name><name><surname>Frederickson</surname><given-names>W. L.</given-names></name><name><surname>Roger-Christoph</surname><given-names>S.</given-names></name><name><surname>Benhamou</surname><given-names>D.</given-names></name><name><surname>Cohen</surname><given-names>S. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Phenylephrine added to prophylactic ephedrine infusion during spinal anesthesia for elective cesarean section</article-title>. <source>Anesthesiology</source>
<volume>95</volume>, <fpage>668</fpage>&#x02013;<lpage>674</lpage>
<pub-id pub-id-type="doi">10.1097/00000542-200109000-00020</pub-id><pub-id pub-id-type="pmid">11575540</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngan Kee</surname><given-names>W. D.</given-names></name><name><surname>Khaw</surname><given-names>K. S.</given-names></name><name><surname>Lau</surname><given-names>T. K.</given-names></name><name><surname>Ng</surname><given-names>F. F.</given-names></name><name><surname>Chui</surname><given-names>K.</given-names></name><name><surname>Ng</surname><given-names>K. L.</given-names></name></person-group> (<year>2008a</year>). <article-title>Randomised double-blinded comparison of phenylephrine vs ephedrine for maintaining blood pressure during spinal anaesthesia for non-elective caesarean section</article-title>. <source>Anaesthesia</source>
<volume>63</volume>, <fpage>1319</fpage>&#x02013;<lpage>1326</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2044.2008.05635.x</pub-id><pub-id pub-id-type="pmid">19032300</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngan Kee</surname><given-names>W. D.</given-names></name><name><surname>Lee</surname><given-names>A.</given-names></name><name><surname>Khaw</surname><given-names>K. S.</given-names></name><name><surname>Ng</surname><given-names>F. F.</given-names></name><name><surname>Karmakar</surname><given-names>M. K.</given-names></name><name><surname>Gin</surname><given-names>T.</given-names></name></person-group> (<year>2008b</year>). <article-title>A randomized double-blinded comparison of phenylephrine and ephedrine infusion combinations to maintain blood pressure during spinal anesthesia for cesarean delivery: the effects on fetal acid-base status and hemodynamic control</article-title>. <source>Anesth. Analg</source>. <volume>107</volume>, <fpage>1295</fpage>&#x02013;<lpage>1302</lpage>
<pub-id pub-id-type="doi">10.1213/ane.0b013e31818065bc</pub-id><pub-id pub-id-type="pmid">18806043</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissen</surname><given-names>P.</given-names></name><name><surname>Brassard</surname><given-names>P.</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>T. B.</given-names></name><name><surname>Secher</surname><given-names>N. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Phenylephrine but not ephedrine reduces frontal lobe oxygenation following anesthesia-induced hypotension</article-title>. <source>Neurocrit. Care</source>
<volume>12</volume>, <fpage>17</fpage>&#x02013;<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1007/s12028-009-9313-x</pub-id><pub-id pub-id-type="pmid">19957053</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissen</surname><given-names>P.</given-names></name><name><surname>Nielsen</surname><given-names>H. B.</given-names></name><name><surname>van Lieshout</surname><given-names>J. J.</given-names></name><name><surname>Secher</surname><given-names>N. H.</given-names></name></person-group> (<year>2009a</year>). <article-title>Frontal lobe oxygenation is maintained during hypotension following propofol-phentanyl anesthesia</article-title>. <source>AANAJ</source>. <volume>77</volume>, <fpage>271</fpage>&#x02013;<lpage>276</lpage>
<pub-id pub-id-type="pmid">19731845</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissen</surname><given-names>P.</given-names></name><name><surname>Pacino</surname><given-names>H.</given-names></name><name><surname>Frederiksen</surname><given-names>H. J.</given-names></name><name><surname>Novovic</surname><given-names>S.</given-names></name><name><surname>Secher</surname><given-names>N. H.</given-names></name></person-group> (<year>2009b</year>). <article-title>Near-infrared spectroscopy for evaluation of cerebral autoregulation during orthotropic liver transplantation</article-title>. <source>Neurocrit. Care</source>
<volume>11</volume>, <fpage>235</fpage>&#x02013;<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1007/s12028-009-9226-8</pub-id><pub-id pub-id-type="pmid">19421898</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissen</surname><given-names>P.</given-names></name><name><surname>Van Lieshout</surname><given-names>J. J.</given-names></name><name><surname>Novovic</surname><given-names>S.</given-names></name><name><surname>Bundgaard-Nielsen</surname><given-names>M.</given-names></name><name><surname>Secher</surname><given-names>N. H.</given-names></name></person-group> (<year>2009c</year>). <article-title>Techniques of cardiac output measurement during liver transplantation: arterial pulse wave versus thermodilution</article-title>. <source>Liver Transplant</source>. <volume>15</volume>, <fpage>287</fpage>&#x02013;<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1002/lt.21689</pub-id><pub-id pub-id-type="pmid">19242994</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogoh</surname><given-names>S.</given-names></name><name><surname>Sato</surname><given-names>K.</given-names></name><name><surname>Fisher</surname><given-names>J. P.</given-names></name><name><surname>Seifert</surname><given-names>T.</given-names></name><name><surname>Overgaard</surname><given-names>M.</given-names></name><name><surname>Secher</surname><given-names>N. H.</given-names></name></person-group> (<year>2011</year>). <article-title>The effect of phenylephrine on arterial and venous cerebral blood flow in healthy subjects</article-title>. <source>Clin. Physiol. Funct. Imaging</source>
<volume>31</volume>, <fpage>445</fpage>&#x02013;<lpage>451</lpage>
<pub-id pub-id-type="doi">10.1111/j.1475-097X.2011.01040.x</pub-id><pub-id pub-id-type="pmid">21981455</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paulson</surname><given-names>O. B.</given-names></name><name><surname>Strandgaard</surname><given-names>S.</given-names></name><name><surname>Edvinsson</surname><given-names>L.</given-names></name></person-group> (<year>1990</year>). <article-title>Cerebral autoregulation</article-title>. <source>Cerebrovasc. Brain Metab. Rev</source>. <volume>2</volume>, <fpage>161</fpage>&#x02013;<lpage>192</lpage>
<pub-id pub-id-type="pmid">2201348</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remmen</surname><given-names>J. J.</given-names></name><name><surname>Aengevaeren</surname><given-names>W. R.</given-names></name><name><surname>Verheugt</surname><given-names>F. W.</given-names></name><name><surname>van ver Werf</surname><given-names>T.</given-names></name><name><surname>Luijten</surname><given-names>H. E.</given-names></name><name><surname>Bos</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Finapres arterial pulse wave analysis with model flow is not a reliable non-invasive method for assessment of cardiac output</article-title>. <source>Clin. Sci</source>. <volume>103</volume>, <fpage>143</fpage>&#x02013;<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1042/CS20010357</pub-id><pub-id pub-id-type="pmid">12149105</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saravanan</surname><given-names>S.</given-names></name><name><surname>Kocarev</surname><given-names>M.</given-names></name><name><surname>Wilson</surname><given-names>R. C.</given-names></name><name><surname>Watkins</surname><given-names>E.</given-names></name><name><surname>Columb</surname><given-names>M. O.</given-names></name><name><surname>Lyons</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section</article-title>. <source>Br. J. Anaesth</source>. <volume>96</volume>, <fpage>95</fpage>&#x02013;<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1093/bja/aei265</pub-id><pub-id pub-id-type="pmid">16311286</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>K. F.</given-names></name><name><surname>Altman</surname><given-names>D. G.</given-names></name><name><surname>Moher</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials</article-title>. <source>J. Clin. Epi</source>. <volume>63</volume>, <fpage>834</fpage>&#x02013;<lpage>840</lpage>
<pub-id pub-id-type="doi">10.1016/j.jclinepi.2010.02.005</pub-id><pub-id pub-id-type="pmid">20346629</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>L. A.</given-names></name><name><surname>Pfister</surname><given-names>D.</given-names></name><name><surname>Strebel</surname><given-names>S. P.</given-names></name><name><surname>Radolovich</surname><given-names>D.</given-names></name><name><surname>Smielewski</surname><given-names>P.</given-names></name><name><surname>Czosnyka</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Near-infrared spectroscopy can monitor dynamic cerebral autoregulation in adults</article-title>. <source>Neurocrit. Care</source>
<volume>10</volume>, <fpage>122</fpage>&#x02013;<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1007/s12028-008-9140-5</pub-id><pub-id pub-id-type="pmid">18807218</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Asahina</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>A.</given-names></name><name><surname>Hattori</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Cerebral oxygenation monitoring for detecting critical cerebral hypoperfusion in patients with multiple system atrophy during the head-up tilt test</article-title>. <source>Intern. Med</source>. <volume>47</volume>, <fpage>1681</fpage>&#x02013;<lpage>1687</lpage>
<pub-id pub-id-type="doi">10.2169/internalmedicine.47.1094</pub-id><pub-id pub-id-type="pmid">18827416</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>C. O.</given-names></name></person-group> (<year>2012</year>). <article-title>Defining the characteristic relationship between arterial pressure and cerebral flow</article-title>. <source>J. Appl. Physiol</source>. <volume>15</volume>, <fpage>1194</fpage>&#x02013;<lpage>1200</lpage>
<pub-id pub-id-type="doi">10.1152/japplphysiol.00783.2012</pub-id><pub-id pub-id-type="pmid">22961266</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Lieshout</surname><given-names>J. J.</given-names></name><name><surname>Pott</surname><given-names>F.</given-names></name><name><surname>Madsen</surname><given-names>P. L.</given-names></name><name><surname>van Goudoever</surname><given-names>J.</given-names></name><name><surname>Secher</surname><given-names>N. H.</given-names></name></person-group> (<year>2001</year>). <article-title>Muscle tensing during standing: effects on cerebral tissue oxygenation and cerebral artery blood velocity</article-title>. <source>Stroke</source>
<volume>32</volume>, <fpage>1546</fpage>&#x02013;<lpage>1551</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.32.7.1546</pub-id><pub-id pub-id-type="pmid">11441199</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vesser</surname><given-names>M.</given-names></name><name><surname>Hofmann</surname><given-names>T.</given-names></name><name><surname>Roth</surname><given-names>R.</given-names></name><name><surname>Kl&#x000f6;hr</surname><given-names>S.</given-names></name><name><surname>Rossaint</surname><given-names>R.</given-names></name><name><surname>Hessen</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Vasopressors for management of hypotension after spinal anesthesia for elective caesarean section. Systematic review and cumulative meta-analysis</article-title>. <source>Acta Anaesthesiol. Scand</source>. <volume>56</volume>, <fpage>810</fpage>&#x02013;<lpage>816</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-6576.2011.02646.x</pub-id><pub-id pub-id-type="pmid">22313496</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Han</surname><given-names>C. B.</given-names></name><name><surname>Qian</surname><given-names>Y. N.</given-names></name></person-group> (<year>2011</year>). <article-title>Comparison of effects in puerpera and fetus with ephedrine and phenylephrine during a cesarean delivery</article-title>. <source>J. Chin. Med. Assoc</source>. <volume>91</volume>, <fpage>2195</fpage>&#x02013;<lpage>2198</lpage>
<pub-id pub-id-type="pmid">22094037</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshitani</surname><given-names>K.</given-names></name><name><surname>Kawaguchi</surname><given-names>M.</given-names></name><name><surname>Miura</surname><given-names>N.</given-names></name><name><surname>Okuno</surname><given-names>T.</given-names></name><name><surname>Kanoda</surname><given-names>T.</given-names></name><name><surname>Ohnishi</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Effects of hemoglobin concentration, skull thickness, and the area of the cerebrospinal fluid layer on near-infrared spectroscopy measurements</article-title>. <source>Anesthesiology</source>
<volume>106</volume>, <fpage>458</fpage>&#x02013;<lpage>462</lpage>
<pub-id pub-id-type="doi">10.1097/00000542-200703000-00009</pub-id><pub-id pub-id-type="pmid">17325503</pub-id></mixed-citation></ref></ref-list></back></article>